Ken Sakurai
Overview
Explore the profile of Ken Sakurai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishida H, Imagawa E, Tsunogai T, Saijo N, Ogata J, Sakurai K, et al.
Pediatr Int
. 2025 Jan;
67(1):e15873.
PMID: 39840671
No abstract available.
2.
Nojiri A, Morimoto S, Fukuro E, Okuyama T, Anan I, Kawai M, et al.
Circ J
. 2024 Dec;
89(1):53-61.
PMID: 39631936
Background: Fabry disease is a hereditary metabolic disorder caused by a decrease in or deficiency of the lysosomal enzyme α-galactosidase A. Enzyme replacement therapy or pharmacological chaperone therapy can improve...
3.
Amadori L, Calcagno C, Fernandez D, Koplev S, Fernandez N, Kaur R, et al.
Nat Cardiovasc Res
. 2024 Apr;
2(8):793.
PMID: 38666036
[This corrects the article DOI: 10.1038/s44161-023-00278-y.].
4.
Donaldson L, Vlok R, Sakurai K, Burrows M, McDonald G, Venkatesh K, et al.
Crit Care Med
. 2024 Apr;
52(8):1264-1274.
PMID: 38557802
Objectives: To derive a pooled estimate of the incidence and outcomes of sepsis-associated acute kidney injury (SA-AKI) in ICU patients and to explore the impact of differing definitions of SA-AKI...
5.
Amadori L, Calcagno C, Fernandez D, Koplev S, Fernandez N, Kaur R, et al.
Nat Cardiovasc Res
. 2023 Sep;
2(6):550-571.
PMID: 37771373
The development of new immunotherapies to treat the inflammatory mechanisms that sustain atherosclerotic cardiovascular disease (ASCVD) is urgently needed. Herein, we present a path to drug repurposing to identify immunotherapies...
6.
Maier A, Toner Y, Munitz J, Sullivan N, Sakurai K, Meerwaldt A, et al.
JACC Basic Transl Sci
. 2023 Aug;
8(7):801-816.
PMID: 37547068
In the past 2 decades, research on atherosclerotic cardiovascular disease has uncovered inflammation to be a key driver of the pathophysiological process. A pressing need therefore exists to quantitatively and...
7.
Shimoyama K, Kanzaki G, Okubo A, Nakashima A, Sakurai K, Maruyama Y, et al.
QJM
. 2023 Mar;
116(7):536-537.
PMID: 36892442
No abstract available.
8.
Sakurai K, Singhal N
J Paediatr Child Health
. 2022 Aug;
58(9):1525-1531.
PMID: 35932281
With the advancement in technology and increasing familiarity, the use of extracorporeal membrane oxygenation (ECMO) has expanded in the past decade. Although ECMO can be lifesaving for critically ill children,...
9.
Anan I, Sakuma T, Fukuro E, Morimoto S, Nojiri A, Kawai M, et al.
Mol Genet Metab Rep
. 2022 Jul;
31:100858.
PMID: 35782602
Aims: T1 mapping in cardiac magnetic resonance imaging enables us to distinguish various myocardial diseases showing left ventricular hypertrophy. Fabry disease is a lysosomal storage disorder causing the accumulation of...
10.
Toner Y, Ghotbi A, Naidu S, Sakurai K, van Leent M, Jordan S, et al.
Sci Rep
. 2022 Apr;
12(1):6185.
PMID: 35418569
In recent years, cardiovascular immuno-imaging by positron emission tomography (PET) has undergone tremendous progress in preclinical settings. Clinically, two approved PET tracers hold great potential for inflammation imaging in cardiovascular...